Saint Luke's Newsroom
Dec. 4, 2023

Kansas City Star: Saint Luke’s Finalizes Merger Plans with BJC in St. Louis. What Do Patients Need to Know?
Two of Missouri’s biggest healthcare systems will merge in 2024.
Dec. 1, 2023

KCTV: Vaccine Safety for Moms-To-Be
While it is early in the season for respiratory illness, the importance of vaccines for pregnant people is top of mind, especially with the holiday season here.
Modern Healthcare logo
Nov. 29, 2023

Modern Healthcare: BJC, Saint Luke's of Kansas City Merger to Close Soon
Saint Luke’s Health System CEO, Melinda L. Estes, MD, and BJC HealthCare President and CEO, Richard Liekweg sat down with Modern Healthcare to discuss the announcement and what the new integrated health system can potentially mean for patients and healthcare in our region.
Nov. 29, 2023

BJC and Saint Luke's Health Systems Reach Definitive Agreement to Combine and Accelerate Shared Commitment to Deliver Extraordinary Patient Care
Patient-Centric Health System Will Advance Innovative Models of Care and Improve Health Across Missouri, Illinois and Kansas
Nov. 29, 2023

Research Shows Common Glucose-Lowering Therapy May Slow Aging and Improve Lifespan and Overall Health
New scientific paper proposes SGLT inhibitors as a therapy to slow aging at the cellular level and improve longevity.
Thumbnail
Nov. 27, 2023

KCUR: Many Adults Are Dissatisfied with Life. Kansas City-Area Experts Say Gratitude and Connection Help
KCUR talked to Kadie Harry about how individualized approaches can lead to more fulfilled lives.
Nov. 24, 2023

Health News You Can Use: Precision Oncology for Lung Cancer
We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.
Nov. 20, 2023

Hedrick Medical Group and Joy Toy Partner to Host Local Toy Drive
The deadline to drop off donations at Hedrick Medical Group is Thursday, November 30.
Nov. 16, 2023

Cardiovascular Business: TAVR Linked to Favorable Outcomes for Asymptomatic and Minimally Symptomatic Patients—But is it Necessary?
TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.